Login / Signup

Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology.

Michal LevyMichal KovoHadas MirembergNoa AnchelHadas Ganer HermanJacob BarLetizia SchreiberEran Weiner
Published in: Journal of perinatology : official journal of the California Perinatal Association (2020)
SSRI use during pregnancy was independently associated with adverse neonatal outcome and placental FVM.
Keyphrases
  • birth weight
  • pregnancy outcomes
  • emergency department
  • metabolic syndrome
  • glycemic control
  • drug induced